U.S. Injectable Compounding Pharmacy Market, By Molecule (Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl/Bupivacaine, Morphine, Amiodarone, Fentanyl, Heparin, Ketamine, Dextrose, Hydromorphone, Bupivacaine, Lidocaine, BKK (Bupivacaine, Ketorolac, Ketamine), RCK (Ropivacaine, Clonidine, Ketorolac), RKK (Ropivacaine, Ketorolac, Ketamine), Norepinephrine, Diltiazem, Vasopressin, Others), By Packaging Type (Vials, Ampoules, Prefilled Syringes, Others), By Pharmacy Type (503A Pharmacies, 503B Pharmacies)
U.S. Injectable Compounding Pharmacy Market, By Molecule (Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl/Bupivacaine, Morphine, Amiodarone, Fentanyl, Heparin, Ketamine, Dextrose, Hydromorphone, Bupivacaine, Lidocaine, BKK (Bupivacaine, Ketorolac, Ketamine), RCK (Ropivacaine, Clonidine, Ketorolac), RKK (Ropivacaine, Ketorolac, Ketamine), Norepinephrine, Diltiazem, Vasopressin, Others), By Packaging Type (Vials, Ampoules, Prefilled Syringes, Others), By Pharmacy Type (503A Pharmacies, 503B Pharmacies)
An injectable compounding pharmacy is a specialized healthcare facility that plays a critical role in customizing and preparing injectable medications to meet the unique needs of patients. Unlike traditional retail pharmacies, these compounding pharmacies have the expertise, equipment, and facilities to compound, or create sterile injectable medications from raw materials. This process involves combining, altering, or formulating drug ingredients to provide patients with personalized solutions at the time when standard and commercially available medications are not suitable. These pharmacies cater to a wide range of patients, including those with allergies, intolerances, or specific dosing requirements that cannot be met by mass-produced drugs. Injectable medications prepared in compounding pharmacies are used to treat various medical conditions, such as pain management, hormone therapy, fertility treatments, and intravenous nutrition. Injectable compounding pharmacies often collaborate closely with healthcare providers to develop tailored medication solutions. Their services are especially vital during drug shortages, emergencies, or when specific medications are unavailable, as they provide a lifeline for patients who require unique and customized treatment options. In short, injectable compounding pharmacies offers valuable resource for personalized medicines and thereby ensuring that the patients receive the most effective and safe injectable medications tailored to their specific needs.
Market Dynamics
The U.S. injectable compounding pharmacy market is set to grow due to supply chain resilience, and ongoing healthcare challenges of drug shortages, making it a vital component of the healthcare ecosystem. Further, the growing aging population is increasing the demand for personalized medications and this is expected to drive the compounding pharmacy. For instance, in May 2023, according to an article published by the United States Census Bureau in May 2023, 1 in every 6 people in the U.S. was aged 65 years or above in 2020. This older population is more vulnerable to chronic diseases and thus creating demand for injectable compounding pharmacy in U.S.
Key features of the study:
The report provides an in-depth analysis of the U.S. injectable compounding pharmacy market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for the market
The study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the U.S. injectable compounding pharmacy market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of the study include Central Admixture Pharmacy Services, Inc., Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc., Avella Specialty Pharmacy, Atlas Pharmaceuticals, Empower Pharmacy, Carie Boyd’S Prescription Shop, Edge Pharma, Imprimis NJOF, LLC, IntegraDose Compounding Services, LLC, Wells Pharma of Houston, LLC, US Compounding Inc., SCA Pharma, Leiters Health, Medivant Healthcare and Vertisis Custom Pharmacy
Insights from the report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
S. injectable compounding pharmacy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. injectable compounding pharmacy market
U.S. Injectable Compounding Pharmacy Market Detailed Segmentation:
By Molecule:
Acetaminophen
Phenylephrine
Midazolam
Esmolol
Vancomycin
Epinephrine
Adenocaine
Fentanyl/Bupivacaine
Morphine
Amiodarone
Fentanyl
Heparin
Ketamine
Dextrose
Hydromorphone
Bupivacaine
Lidocaine
BKK (Bupivacaine, Ketorolac, Ketamine)
RCK (Ropivacaine, Clonidine, Ketorolac)
RKK (Ropivacaine, Ketorolac, Ketamine)
Norepinephrine
Diltiazem
Vasopressin
Others
By Packaging Type:
Vials
Ampoules
Prefilled Syringes
Others
By Pharmacy Type:
503A Pharmacies
503B Pharmacies
Company Profiles
Central Admixture Pharmacy Services, Inc.
Nephron Pharmaceuticals Corporation
QuVa Pharma
Olympia Pharmacy
ASP Cares
Fagron Compounding Pharmacies
Athenex, Inc.
Avella Specialty Pharmacy
Atlas Pharmaceuticals
Empower Pharmacy
Carie Boyd’S Prescription Shop
Edge Pharma
Imprimis NJOF, LLC
IntegraDose Compounding Services, LLC
Wells Pharma of Houston, LLC
US Compounding Inc.
SCA Pharma
Leiters Health
Medivant Healthcare
Vertisis Custom Pharmacy
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Molecule
Market Snippet, By Packaging Type
Market Snippet, By Pharmacy Type
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Recent Product Approvals/Launches
Mergers, Acquisitions, and Collaborations
Regulatory Scenario
Recent Trends
Key Developments
PEST Analysis
Porter’s Analysis
4. U.S. Injectable Compounding Pharmacy Market - COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. U.S. Injectable Compounding Pharmacy Market, By Molecule, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Acetaminophen
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Phenylephrine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Midazolam
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Esmolol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Vancomycin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Epinephrine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Adenocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Fentanyl/Bupivacaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Morphine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Amiodarone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Fentanyl
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Heparin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Ketamine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Dextrose
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Hydromorphone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Bupivacaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Lidocaine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
BKK (Bupivacaine, Ketorolac, Ketamine)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
RCK (Ropivacaine, Clonidine, Ketorolac)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
RKK (Ropivacaine, Ketorolac, Ketamine)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Norepinephrine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Diltiazem
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Vasopressin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
6. U.S. Injectable Compounding Pharmacy Market, By Packaging Type, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Vials
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Ampoules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Prefilled Syringes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
7. U.S. Injectable Compounding Pharmacy Market, By Pharmacy Type, 2018-2030, (US$ Mn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
503A Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
503B Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Segment Trends
8. Competitive Landscape
Company Profiles
Central Admixture Pharmacy Services, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Nephron Pharmaceuticals Corporation
QuVa Pharma
Olympia Pharmacy
ASP Cares
Fagron Compounding Pharmacies
Athenex, Inc.
Avella Specialty Pharmacy
Atlas Pharmaceuticals
Empower Pharmacy
Carie Boyd’S Prescription Shop
Edge Pharma
Imprimis NJOF, LLC
IntegraDose Compounding Services, LLC
Wells Pharma of Houston, LLC
US Compounding Inc.
SCA Pharma
Leiters Health
Medivant Healthcare
Vertisis Custom Pharmacy
Analysts’ Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 9 market data tables and 37 figures on “U.S. Injectable Compounding Pharmacy Market” - Global forecast to 2030